VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Mar 16, 2021
Document Date
Mar 15, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Jones Aranthan II
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |